PE20180574A1 - Lisobactina para su uso en el tratamiento de la mastitis bovina - Google Patents

Lisobactina para su uso en el tratamiento de la mastitis bovina

Info

Publication number
PE20180574A1
PE20180574A1 PE2018000260A PE2018000260A PE20180574A1 PE 20180574 A1 PE20180574 A1 PE 20180574A1 PE 2018000260 A PE2018000260 A PE 2018000260A PE 2018000260 A PE2018000260 A PE 2018000260A PE 20180574 A1 PE20180574 A1 PE 20180574A1
Authority
PE
Peru
Prior art keywords
treatment
lisobactin
bovine mastitis
mastitis
bovine
Prior art date
Application number
PE2018000260A
Other languages
English (en)
Inventor
Guido Schiffer
Stefan Falker
Gert Daube
Kristine Fraatz
Wolfgang Wiehl
Johannes Kobberling
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of PE20180574A1 publication Critical patent/PE20180574A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a lisobactina para su uso en el tratamiento de la mastitis bovina.
PE2018000260A 2015-08-17 2016-08-16 Lisobactina para su uso en el tratamiento de la mastitis bovina PE20180574A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15181209 2015-08-17

Publications (1)

Publication Number Publication Date
PE20180574A1 true PE20180574A1 (es) 2018-04-04

Family

ID=53871958

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2018000260A PE20180574A1 (es) 2015-08-17 2016-08-16 Lisobactina para su uso en el tratamiento de la mastitis bovina

Country Status (27)

Country Link
US (2) US20180346518A1 (es)
EP (1) EP3337494B1 (es)
JP (1) JP6921805B2 (es)
KR (1) KR20180040674A (es)
CN (1) CN107921088B (es)
AR (1) AR105728A1 (es)
AU (1) AU2016310221B2 (es)
BR (1) BR112018003150A2 (es)
CA (1) CA2995648C (es)
CO (1) CO2018001531A2 (es)
CR (1) CR20180110A (es)
DK (1) DK3337494T3 (es)
ES (1) ES2788734T3 (es)
HR (1) HRP20200427T1 (es)
HU (1) HUE048864T2 (es)
IL (1) IL257342A (es)
LT (1) LT3337494T (es)
MX (1) MX2018002020A (es)
PE (1) PE20180574A1 (es)
PH (1) PH12018500339A1 (es)
PL (1) PL3337494T3 (es)
PT (1) PT3337494T (es)
RU (1) RU2741764C2 (es)
SI (1) SI3337494T1 (es)
TW (1) TW201717991A (es)
WO (1) WO2017029271A1 (es)
ZA (1) ZA201801788B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266247A (en) 1985-03-25 1990-02-27 Adrienne A. Tymiak Antibiotic prepared from lysobacter sp. sc 14,067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンａおよびｂならびにその製造法
DE10320781A1 (de) 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide
DE102004051025A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004051024A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004051023A1 (de) 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004053407A1 (de) * 2004-11-05 2006-05-11 Bayer Healthcare Ag Acylierte Nonadepsipeptide II
DE102004053410A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102004053409A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Verfahren zur gezielten Herstellung von Lysobactinfragmenten
DE102006003443A1 (de) 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
DE102006018080A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide

Also Published As

Publication number Publication date
CR20180110A (es) 2018-04-27
CA2995648A1 (en) 2017-02-23
AU2016310221B2 (en) 2021-08-05
AR105728A1 (es) 2017-11-01
WO2017029271A1 (en) 2017-02-23
HUE048864T2 (hu) 2020-08-28
EP3337494A1 (en) 2018-06-27
ZA201801788B (en) 2019-10-30
PT3337494T (pt) 2020-05-11
CN107921088A (zh) 2018-04-17
RU2741764C2 (ru) 2021-01-28
US20180346518A1 (en) 2018-12-06
CA2995648C (en) 2024-02-20
TW201717991A (zh) 2017-06-01
PH12018500339A1 (en) 2018-08-20
ES2788734T3 (es) 2020-10-22
LT3337494T (lt) 2020-04-10
PL3337494T3 (pl) 2020-09-07
EP3337494B1 (en) 2020-03-11
US20230125394A1 (en) 2023-04-27
AU2016310221A1 (en) 2018-03-01
KR20180040674A (ko) 2018-04-20
DK3337494T3 (da) 2020-05-25
RU2018109421A3 (es) 2019-11-13
JP2018523677A (ja) 2018-08-23
SI3337494T1 (sl) 2020-06-30
CN107921088B (zh) 2022-05-27
BR112018003150A2 (pt) 2018-09-25
HRP20200427T1 (hr) 2020-06-12
IL257342A (en) 2018-03-29
MX2018002020A (es) 2018-06-15
JP6921805B2 (ja) 2021-08-18
CO2018001531A2 (es) 2018-07-10
RU2018109421A (ru) 2019-09-19

Similar Documents

Publication Publication Date Title
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
BR112018009706A2 (pt) composições compreendendo cepas bacterianas
BR112018009213A2 (pt) composições compreendendo cepas bacterianas
CL2016001871A1 (es) Anticuerpos humanos para pd-1
BR112017025004A2 (pt) composições compreendendo cepas bacterianas
BR112017025003A2 (pt) composições compreendendo cepas bacterianas
CL2015002335A1 (es) Derivados de 2-aminopirimidina para el tratamiento de infecciones víricas.
CO2017002708A2 (es) Triazolopirazinonas como inhibidores de pde1
TWD174683S (zh) 戒指
BR112016025427A2 (pt) processos de preparação de um inibidor de jak1 e formas do mesmo
ECSP17015977A (es) Terapia de combinacion
CL2015003281S1 (es) Parche para edema
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
BR112019010131A2 (pt) entrega transdérmica de agentes grandes
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
EA201791716A1 (ru) Фармацевтический состав
BR112017025264A2 (pt) tratamento de prurido
DK3402573T3 (da) Aminosyreholdig sammensætning
CR20160322A (es) Hexahidrofuropirroles como inhibidores de pde1
PE20180574A1 (es) Lisobactina para su uso en el tratamiento de la mastitis bovina
DOP2015000290A (es) Benzoxazoles sustituidos
CR20150352A (es) Nuevas composiciones antifúngicidas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal